source
- FDA and CMS work to prevent regulatory clash as states move to test clinical AIOfficials at the FDA and CMS are working behind the scenes to avoid a regulatory clash as more states plan to test artificial intelligence tools that perform clinical tasks. The tension arises fro…
- FDA rolls out new inspection coordination plan, lifts estradiol patch warning and HHS permits compounding of six peptidesFDA's drug center and inspections office have agreed on a new concept of operations (ConOps) to better coordinate inspections and compliance activities. A U.S. senator introduced draft legislation…